Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy
dc.authorid | Adanir, Haydar/0000-0003-1899-5846 | |
dc.authorid | Boyacioglu, Ahmet Sedat/0000-0002-9370-1126 | |
dc.contributor.author | Gunduz, Feyza | |
dc.contributor.author | Durak, Serdar | |
dc.contributor.author | Unsal, Yasemin | |
dc.contributor.author | Demir, Mehmet | |
dc.contributor.author | Ellik, Zeynep Melekoglu | |
dc.contributor.author | Yildirim, Abdullah Emre | |
dc.contributor.author | Mehdiyev, Shahin | |
dc.date.accessioned | 2024-09-18T21:08:00Z | |
dc.date.available | 2024-09-18T21:08:00Z | |
dc.date.issued | 2022 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.endpage | S858 | en_US |
dc.identifier.issn | 0168-8278 | |
dc.identifier.issn | 1600-0641 | |
dc.identifier.startpage | S858 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/14080 | |
dc.identifier.volume | 77 | en_US |
dc.identifier.wos | WOS:000826275104254 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Journal of Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy | en_US |
dc.type | Conference Object | en_US |